Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick? – Summary

Discover the complexities of identifying and treating iron deficiency in chronic inflammatory conditions, such as chronic kidney disease and heart failure. This article summary explains the article’s practical methods for interpreting ferritin and transferrin saturation levels, alongside guidance on selecting oral or intravenous iron therapies. Derived from the 2020 ASH Education Program.

Chapter 21 — Metabolite Binding Mechanisms

Metabolite binding is a central stabilizing action within the Gate architecture. Gates 3 and 5 rely on selective adsorption of bile acids, microbial byproducts, and other luminal compounds that would otherwise sustain epithelial injury, immune activation, and pathobiont advantage. This chapter details the mechanistic pathways through which binding alters gut physiology, microbial selection, and enterohepatic … Read more

Chapter 31 — Metagenomic Data

This chapter consolidates the primary shotgun metagenomic outputs used throughout the book. The values are presented without interpretation; they serve as the dataset reference for all ecological and mechanistic reasoning in Parts I–IV. Two full shotgun metagenomic datasets form the empirical foundation: Dataset 1: August 2024 Dataset 2: September 2025 Both include taxonomic composition, functional … Read more

Chapter 32 — Functional Scores

This chapter consolidates the functional pathway scores and ecological function metrics derived from the two shotgun metagenomic datasets (August 2024 and September 2025). These values are presented as raw functional outputs without interpretation. They serve as the functional reference archive for all mechanistic reasoning in Parts I–IV. Functional categories include SCFA pathways, bile-acid conversion pathways, … Read more

Chapter 33 — Clinical Lab Trends

This chapter consolidates the clinical laboratory data relevant to the ecological, epithelial, metabolic, and immunological domains described throughout the book. The values are presented without interpretation. Their purpose is to provide a stable reference set for ecological modeling, mechanistic inference, and timeline correlation in Parts I–IV. Laboratory markers include inflammatory indicators, hepatic and biliary markers, … Read more

Chapter 34 — Intervention Timeline

This chapter provides a chronological record of key interventions, events, and system-state transitions spanning late 2023 through late 2025. The purpose is archival: to maintain an accurate historical sequence that can be mapped against metagenomic data, clinical laboratory trends, ecological indicators, and the mechanistic interpretation structure used throughout the book. No interpretation is provided here. … Read more

Chapter 35 — Monitoring Framework

This chapter documents the structured monitoring framework used to track ecological, epithelial, metabolic, and immunological behavior over the 2023–2025 period. The information below describes the domains observed, the data streams maintained, and the logic used to track system stability or volatility over time. This chapter is non-interpretive and functions as a methodological archive. — 1. … Read more

PART V — Data and Analytical Appendices

**Reference datasets, scoring frameworks, laboratory trends, timelines, and monitoring structures** Part V consolidates all empirical data and methodological archives that support the ecological and mechanistic interpretation in Parts I–IV. The chapters in this section provide the raw materials—metagenomic results, functional pathway scores, clinical laboratory patterns, intervention chronology, and monitoring frameworks—that anchor the system model in … Read more